In a move lauded by experts in the field of hormone optimization, the United States Food and Drug Administration (FDA) — the preeminent government body that regulates all pharmaceutical products sold in America — recently made a crucial and long-awaited decision regarding the testosterone used in hormone replacement therapy (HRT). 

From Reuters (emphasis my own):

“The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on results from clinical and post-market studies testing the products for blood pressure and cardiovascular effects.

The FDA said it is recommending label changes based on results from a clinical trial testing cardiovascular effects of testosterone-replacement therapy in middle-aged and older men with hypogonadism – a condition in which the body does not produce enough of the testosterone hormone. 

Results from the trial concluded there was no increase in the risk of adverse cardiovascular outcomes in men using testosterone for hypogonadism.”

By eliminating the unscientific cardiovascular risk warning previously required on all testosterone products sold in the United States, the agency overturned years of precedent in which every testosterone prescription came with language that stoked unwarranted fear in the patients who rely on exogenous testosterone to treat low T. 

“Based on FDA’s review of the results from a large clinical trial showing the use of testosterone therapy did not increase the risk of heart attack or stroke compared to an inactive treatment called a placebo,” the FDA confirmed in a February press release, “we are removing information about this risk from the Boxed Warning on all prescription testosterone products.”

As I and others in the anti-aging healthcare field have pleaded for years, the warning label previously affixed to all testosterone products licensed for sale in the United States by the FDA always ran counter to the cornucopia of clinical literature on the association between testosterone levels and heart health.   

It’s never too late to make the right call. But, of course, the warning should have been removed years ago, as it was never supported by a broad, holistic view of the science. The devil, as they say, is in the details; the studies that purported to show a link between testosterone therapy and increased heart attack or stroke risk, which the FDA and other groups cited to justify the warnings, were methodologically flawed and therefore arrived at incorrect conclusions. 

In my forthcoming book, soon to be released, “Are You Hormone Curious? The Science of Hormone Therapy for Men and Women Explained,” I take readers on a deep dive into the literature on testosterone, cardiovascular health, and hormone replacement therapy for correcting low T (known clinically as hypogonadism) with more citations to real research than anyone could ask for. 

So, what does the literature say about the complex and crucial interplay between the male sex hormone and heart health?

Rather than testosterone supplementation posing a health risk to men with low T, the inverse is true: untreated low testosterone is tied to increased risk of adverse cardiovascular events while carefully titrated testosterone therapy actually reduces cardiovascular events and improves heart and blood vessel vitality.  

From Asian Journal of Andrology (emphasis my own):

“It has now been demonstrated in several large longitudinal cohort studies of men with and without coronary disease that low baseline testosterone is a significant risk marker of increased all-cause and cardiovascular mortality.”

And, per the European Heart Journal, the restoration of optimal testosterone levels “significantly reduces” heart attack and stroke risk (emphasis my own):

“We retrospectively examined 83 010 male veterans with documented low [testosterone] levels…

In this large observational cohort with extended follow-up, normalization of [testosterone] levels after TRT was associated with a significant reduction in all-cause mortality, [heart attack], and stroke.”

What’s more, we’ve seen a precipitous and seriously concerning decline in testosterone levels at the population level in American men over recent decades — a looming public health disaster with far-reaching consequences that has thus far not received nearly the coverage that it deserves from the public health community at large.

Several studies back up the plummeting T counts in Western men, likely due to a confluence of factors like sedentary lifestyle, hormone disruptors in the food and water, obesity and metabolic dysfunction, and lack of proper sleep. 

From Urology Times Journal, 2020 (emphasis my own):

“”From 1999 to 2016, testosterone levels have declined in adolescent and young adult men (AYA)… After controlling for confounders—including year of study, age, race, BMI, comorbidity status, alcohol and smoking use, and level of physical activity—total testosterone was lower among men in the later (2011-2016) versus earlier (1999-2000) cycles…

We’ve seen that lower values of testosterone have been associated with increased comorbidities and an increased risk for all-cause mortality. This decline specifically, in these young adult men, with increased obesity may lead to an increase in precocious cancer.”

It’s my belief, as a clinical practitioner working hands-on with patients affected by low T, that we need a true galvanization of public health resources to tackle this problem, to get to root causes, and restore hormone health at the population level. But right now, for men already with clinically deficient testosterone levels, HRT is a godsend. I know firsthand the transformative power of testosterone therapy because I see patients achieve miraculous health turnarounds on a regular basis in my practice. 

A critical point, which should always be emphasized, is that testosterone replacement therapy and other forms of hormone therapy are only safe when they are prescribed under the care of an accredited, experienced hormone expert like me. In the absence of professional guidance, there are of course risks associated with self-administering any therapeutic as potent as exogenous testosterone.

For added safety and efficacy, in my practice at LowTE Florida, I utilize only bioidentical testosterone for testosterone replacement therapy (TRT) rather than the synthetic hormone products used in the majority of clinics. 

In a nutshell, the advantage that bioidentical hormones enjoy over conventional hormone products is that, at the molecular level, they perfectly match the structure of natural hormones, which means they are better utilized and much safer than competing synthetic products. 

To learn more about the superior benefits of bioidentical hormone replacement therapy (BHRT) and all related services I offer at my leading anti-aging healthcare clinic LowTE Florida, please don’t hesitate to contact me and begin your journey to restored vitality. 

As always, be healthy and be your best